A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer
Clinical trial NCT03031691 · COMPLETED
Trial details
- NCT number
- NCT03031691
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2017-05-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.